The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Forced degradation of recombinant monoclonal antibodies: A practical guide
Open accessAbstract
Forced degradation studies have become integral to the development of recombinant monoclonal antibody therapeutics by serving a variety of objectives from early stage manufacturability evaluation to supporting comparability assessments both pre- and post- marketing approval. This review summarizes the regulatory guidance scattered throughout different documents to highlight the expectations from various agencies such as the Food and Drug Administration and European Medicines Agency. The various purposes for forced degradation studies, commonly used conditions and the major degradation pathways under each condition are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Development of forced degradation and stability indicating studies of drugs—A review
Blessy, M., Patel, R. D., Prajapati, P. N., & Agrawal, Y. K. (2014) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2013.09.003 · Cited by 1,032
Strategies and challenges for the next generation of therapeutic antibodies
Beck, A., Wurch, T., Bailly, C., & Corvaia, N. (2010) · Nature Reviews Immunology · doi:10.1038/nri2747 · Cited by 847
Self-citationIdentification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Heterogeneity of Monoclonal Antibodies
Liu, H., Gaza-Bulseco, G., Faldu, D., Chumsae, C., & Sun, J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21180 · Cited by 481
Self-citationCreed, D. (1984) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1984.tb03890.x · Cited by 477
Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody
Kiese, S., Papppenberger, A., Friess, W., & Mahler, H.-C. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21328 · Cited by 397
Protect from Light: Photodegradation and Protein Biologics
Kerwin, B. A., & Remmele, R. L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20815 · Cited by 354
Classification and Characterization of Therapeutic Antibody Aggregates
Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., & Narhi, L. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160457 · Cited by 316
Induction and analysis of aggregates in a liquid IgG1-antibody formulation
Mahler, H.-C., Müller, R., Frieβ, W., Delille, A., & Matheus, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.004 · Cited by 309
Creed, D. (1984) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1984.tb03891.x · Cited by 295
Alt, N., Zhang, T. Y., Motchnik, P., Taticek, R., Quarmby, V., Schlothauer, T., Beck, H., Emrich, T., & Harris, R. J. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.06.005 · Cited by 294
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005) · Analytical Chemistry · doi:10.1021/ac0494174 · Cited by 266
Chelius, D., Rehder, D. S., & Bondarenko, P. V. (2005) · Analytical Chemistry · doi:10.1021/ac050672d · Cited by 263
Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
Structure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine Oxidation
Liu, D., Ren, D., Huang, H., Dankberg, J., Rosenfeld, R., Cocco, M. J., Li, L., Brems, D. N., & Remmele, R. L. (2008) · Biochemistry · doi:10.1021/bi702238b · Cited by 261
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Wang, W., Vlasak, J., Li, Y., Pristatsky, P., Fang, Y., Pittman, T., Roman, J., Wang, Y., Prueksaritanont, T., & Ionescu, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.009 · Cited by 257
Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress
Hawe, A., Kasper, J. C., Friess, W., & Jiskoot, W. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.001 · Cited by 255
Vlasak, J., Bussat, M. C., Wang, S., Wagner-Rousset, E., Schaefer, M., Klinguer-Hamour, C., Kirchmeier, M., Corvaïa, N., Ionescu, R., & Beck, A. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.05.043 · Cited by 252
Self-citationForced Degradation of Therapeutic Proteins
Hawe, A., Wiggenhorn, M., van de Weert, M., Garbe, J. H. O., Mahler, H.-C., & Jiskoot, W. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22812 · Cited by 248
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Jarasch, A., Koll, H., Regula, J. T., Bader, M., Papadimitriou, A., & Kettenberger, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24430 · Cited by 242
Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fcγ receptors
Bertolotti-Ciarlet, A., Wang, W., Lownes, R., Pristatsky, P., Fang, Y., McKelvey, T., Li, Y., Li, Y., Drummond, J., Prueksaritanont, T., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.002 · Cited by 235
Quan, C., Alcala, E., Petkovska, I., Matthews, D., Canova-Davis, E., Taticek, R., & Ma, S. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.027 · Cited by 206
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Pan, H., Chen, K., Chu, L., Kinderman, F., Apostol, I., & Huang, G. (2009) · Protein Science · doi:10.1002/pro.45 · Cited by 203
Cacia, J., Keck, R., Presta, L. G., & Frenz, J. (1996) · Biochemistry · doi:10.1021/bi951526c · Cited by 202
Kueltzo, L. A., Wang, W. E. I., Randolph, T. W., & Carpenter, J. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21110 · Cited by 200
Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions
Luo, Q., Joubert, M. K., Stevenson, R., Ketchem, R. R., Narhi, L. O., & Wypych, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160440 · Cited by 199
Chumsae, C., Gaza-Bulseco, G., Sun, J., & Liu, H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.11.050 · Cited by 191
Self-citationAndya, J. D., Maa, Y.-F., Costantino, H. R., Nguyen, P.-A., Dasovich, N., Sweeney, T. D., Hsu, C. C., & Shire, S. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018805232453 · Cited by 190
Dillon, T. M., Bondarenko, P. V., Rehder, D. S., Pipes, G. D., Kleemann, G. R., & Ricci, M. S. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.01.016 · Cited by 189
Non-enzymatic hinge region fragmentation of antibodies in solution
Cordoba, A. J., Shyong, B.-J., Breen, D., & Harris, R. J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.12.033 · Cited by 188
Yan, B., Steen, S., Hambly, D., Valliere-Douglass, J., Bos, T. V., Smallwood, S., Yates, Z., Arroll, T., Han, Y., Gadgil, H., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21655 · Cited by 174
In vitro and in vivo modifications of recombinant and human IgG antibodies
Liu, H., Ponniah, G., Zhang, H.-M., Nowak, C., Neill, A., Gonzalez-Lopez, N., Patel, R., Cheng, G., Kita, A. Z., & Andrien, B. (2014) · mAbs · doi:10.4161/mabs.29883 · Cited by 168
Self-citationWei, Z., Feng, J., Lin, H.-Y., Mullapudi, S., Bishop, E., Tous, G. I., Casas-Finet, J., Hakki, F., Strouse, R., & Schenerman, M. A. (2007) · Analytical Chemistry · doi:10.1021/ac062311j · Cited by 166
Haberger, M., Bomans, K., Diepold, K., Hook, M., Gassner, J., Schlothauer, T., Zwick, A., Spick, C., Kepert, J. F., Hienz, B., et al. (2014) · mAbs · doi:10.4161/mabs.27876 · Cited by 162
Zhang, A., Singh, S. K., Shirts, M. R., Kumar, S., & Fernández, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0538-y · Cited by 156
Cohen, S. L., Price, C. E., & Vlasak, J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0705994 · Cited by 150
Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping
Kroon, D. J., Baldwin-Ferro, A., & Lalan, P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015894409623 · Cited by 145
Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies
Fesinmeyer, R. M., Hogan, S., Saluja, A., Brych, S. R., Kras, E., Narhi, L. O., Brems, D. N., & Gokarn, Y. R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9792-z · Cited by 141
Telikepalli, S. N., Kumru, O. S., Kalonia, C. K., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23839 · Cited by 137
Analytical techniques used to study the degradation of proteins and peptides: chemical instability
Reubsaet, L., Beijnen, J. H., Bult, A., van Maanen, R. J., Marchal, J. A. D., & UNDERBERG, W. J. M. (1998) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00063-6 · Cited by 130
Liu, H., Gaza‐Bulseco, G., & Sun, J. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.03.053 · Cited by 127
Self-citationThe Use of t-Butyl Hydroperoxide as a Probe for Methionine Oxidation in Proteins
Keck, R. G. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0131 · Cited by 124
Glycation during storage and administration of monoclonal antibody formulations
FISCHER, S., Hoernschemeyer, J., & MAHLER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.04.021 · Cited by 124
Human antibody Fc deamidation in vivo
Liu, D., Enk, J. Z.-V., & Flynn, G. C. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.06.001 · Cited by 124
Arosio, P., Rima, S., & Morbidelli, M. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0885-3 · Cited by 123
Inhibition of Agitation‐Induced Aggregation of an IgG‐Antibody by Hydroxypropyl‐β‐Cyclodextrin
Serno, T., Carpenter, J. F., Randolph, T. W., & Winter, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21931 · Cited by 120
Characterization of antibody aggregation: Role of buried, unpaired cysteines in particle formation
Brych, S. R., Gokarn, Y. R., Hultgen, H., Stevenson, R., Rajan, R. S., & Matsumura, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21868 · Cited by 119
Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule
Folzer, E., diepold, K., Bomans, K., Finkler, C., Schmidt, R., Bulau, P., Huwyler, J., Mahler, H., & Koulov, A. V. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24509 · Cited by 114
Unveiling a Glycation Hot Spot in a Recombinant Humanized Monoclonal Antibody
Boyan, Z., Yang, Y., Yuk, I. H. Y., Pai, R., McKay, P., Eigenbrot, C. W., Dennis, M. S., Katta, V., & Francissen, K. (2008) · Analytical Chemistry · doi:10.1021/ac701810q · Cited by 113
Developability studies before initiation of process development
Yang, X., Xu, W., Schussler, S. D., Benchaar, S. A., Mengisen, S., Antochshuk, V., Cheung, J. K., Mann, L., Babadjanova, Z., Rowand, J. L., et al. (2013) · mAbs · doi:10.4161/mabs.25269 · Cited by 113
Chu, G. C., Chelius, D., Xiao, G., et al. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9241-4 · Cited by 111
Forced degradation studies of biopharmaceuticals: Selection of stress conditions
Tamizi, E., & Jouyban, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.10.016 · Cited by 108
The LC/MS Analysis of Glycation of IGG Molecules in Sucrose Containing Formulations
Gadgil, H. S., Bondarenko, P. V., Pipes, G. D., Rehder, D., McAuley, A., Perico, N., Dillon, T., Ricci, M. S., & Treuheit, M. J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20966 · Cited by 106
Effect of Polysorbate 80 Quality on Photostability of a Monoclonal Antibody
Singh, S. R., Zhang, J., O’Dell, C., Hsieh, M.-C., Goldstein, J., Liu, J., & Srivastava, R. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9759-6 · Cited by 96
Miller, A. K., Hambly, D. M., Kerwin, B. A., Treuheit, M. J., & Gadgil, H. S. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22504 · Cited by 95
Fragmentation of a Recombinant Monoclonal Antibody at Various pH
Gaza‐Bulseco, G., & Liu, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9606-3 · Cited by 95
Self-citationEffect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody
Sinha, S., Zhang, L., Duan, S., Williams, T. D., Vlasak, J., Ionescu, R. M., & Topp, E. M. (2009) · Protein Science · doi:10.1002/pro.173 · Cited by 95
Li, Y., Polozova, A., Gruia, F., & Feng, J. (2014) · Analytical Chemistry · doi:10.1021/ac404218t · Cited by 93
Specific cleavage of immunoglobulin G by copper ions
Smith, M. A., EASTON, M., Everett, P. B., LEWIS, G., PAYNE, M., Riveros‐Moreno, V., & Allen, G. (1996) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1996.tb01105.x · Cited by 92
Banks, D. D., Hambly, D. M., Scavezze, J. L., Siska, C. C., Stackhouse, N., & Gadgil, H. S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21749 · Cited by 92
Dillon, T. M., Bondarenko, P. V., & Ricci, M. S. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.08.058 · Cited by 91
Ghazvini, S., Kalonia, C. K., Volkin, D. B., & Dhar, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.02.027 · Cited by 90
Rates and impact of human antibody glycation in vivo
Goetze, A. M., Liu, D., Arroll, T., Chu, L., & Flynn, G. C. (2011) · Glycobiology · doi:10.1093/glycob/cwr141 · Cited by 88
Sharma, D. K., Oma, P., Pollo, M. J., & Sukumar, M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22046 · Cited by 86
Franey, H., Brych, S. R., Kolvenbach, C. G., & Rajan, R. S. (2010) · Protein Science · doi:10.1002/pro.434 · Cited by 86
Wang, L., Amphlett, G. W., Lambert, J. M., Blättler, W. A., & Zhang, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5267-7 · Cited by 83
Controlling glycation of recombinant antibody in fed‐batch cell cultures
Yuk, I. H. Y., Zhang, B., Yang, Y., Dutina, G., Leach, K., Vijayasankaran, N., Shen, A. Y., Andersen, D. C., Snedecor, B. R., & Joly, J. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23218 · Cited by 83
Chemical and Physical Stability of Chimeric L6, a Mouse−Human Monoclonal Antibody
Paborji, M., Pochopin, N. L., Coppola, W. P., & Bogardus, J. B. (1994) · Pharmaceutical Research · doi:10.1023/a:1018948901599 · Cited by 79
Characterization of Nonenzymatic Glycation on a Monoclonal Antibody
Brady, L. J., Martinez, T., & Balland, A. (2007) · Analytical Chemistry · doi:10.1021/ac7017469 · Cited by 71
Yang, R., Jain, T. S., Lynaugh, H., Nobrega, R. P., Lu, X., Boland, T., Burnina, I., Sun, T., Caffry, I., Brown, M. E., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1290753 · Cited by 65
Valliere‐Douglass, J. F., Jones, L., Shpektor, D., et al. (2008) · Analytical Chemistry · doi:10.1021/ac702245c · Cited by 59
Wang, T., Kumru, O. S., Li, Y., Wang, Y. J., Zhang, J., Kim, J. H., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23645 · Cited by 59
Relevant shaking stress conditions for antibody preformulation development
Eppler, A., Weigandt, M., Hanefeld, A., & Bunjes, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.11.005 · Cited by 57
Human IgG1 Hinge Fragmentation as the Result of H2O2-mediated Radical Cleavage
Yan, B., Yates, Z., Balland, A., & Kleemann, G. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064147 · Cited by 54
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™
Pisupati, K., Benet, A., Tian, Y., Okbazghi, S. Z., Kang, J., Ford, M., Saveliev, S. V., Sen, K. I., Carlson, E. D., Tolbert, T. J., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1347741 · Cited by 53
Zhang, Y. T., Hu, J. J., Pace, A. L., Wong, R. L., Wang, Y. J., & Kao, Y. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.06.018 · Cited by 52
Huh, J. H., White, A. J., Brych, S. R., Franey, H., & Matsumura, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23505 · Cited by 52
Liu, H., Gaza‐Bulseco, G., & Zhou, L. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.11.011 · Cited by 51
Self-citationAssessment of antibody fragmentation by reversed-phase liquid chromatography and mass spectrometry
Liu, H., Gaza‐Bulseco, G., & Lundell, E. O. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.10.015 · Cited by 51
Self-citationOxidative Modification of Glutamine Synthetase by 2,2′-Azobis(2-amidinopropane) Dihydrochloride
Ma, Y.-S., Chao, C., & Stadtman, E. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1076 · Cited by 48
Ponniah, G., Kita, A., Nowak, C., Neill, A., Kori, Y., Rajendran, S., & Liu, H. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02385 · Cited by 47
Self-citationHuang, H. Z., Nichols, A. C., & Liu, D. (2009) · Analytical Chemistry · doi:10.1021/ac802708s · Cited by 46
Recombinant Antibody Color Resulting from Advanced Glycation End Product Modifications
Butko, M. T., Pallat, H., Cordoba, A. J., & Yu, X. C. (2014) · Analytical Chemistry · doi:10.1021/ac5024099 · Cited by 36
Li, W., Yang, B., Zhou, D., Xu, J., Li, W., & Suen, W.-C. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.02.019 · Cited by 36
Rizzo, J. M., Shi, S., Li, Y., Semple, A., Esposito, J. J., Yu, S., Richardson, D., Antochshuk, V., & Shameem, M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24408 · Cited by 33
Valliere‐Douglass, J. F., Connell‐Crowley, L., Jensen, R. M., Schnier, P. D., Trilisky, E. I., Leith, M., Follstad, B. D., Kerr, J., Lewis, N. E., Vunnum, S., et al. (2010) · Protein Science · doi:10.1002/pro.495 · Cited by 20
Nowak, C., Ponniah, G., Cheng, G. C., Kita, A., Neill, A., Kori, Y., & Liu, H. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.12.004 · Cited by 11
Self-citation
Cited by
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Self-citationSawyer, W. S., Srikumar, N., Carver, J., Chu, P. Y., Shen, A., Xu, A., Williams, A. J., Spiess, C., Wu, C., Liu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917383117 · Cited by 55
Wang, J., Chen, J., Studts, J., & Wang, G. (2023) · mAbs · doi:10.1080/19420862.2023.2220149 · Cited by 37
Metadata
- Authors
- Nowak, C., K. Cheung, J., M. Dellatore, S., Katiyar, A., Bhat, R., Sun, J., Ponniah, G., Neill, A., Mason, B., Beck, A., & Liu, H.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2017-09-21
- Volume
- 9
- Issue
- 8
- Pages
- 1217-1230
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W2751949649
- Cited by
- 260
- References
- 88
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.